MSH2 and neoplasm: The remaining VUS case with a dMMR endometrial gland was identified in the carrier of MSH2 exon 1-6 duplication (ID_058), and together with the tumor also demonstrating MSI-H/dMMR by tumor sequencing and a somatic second hit, is supportive of an LP classification for this variant (Table 4).